{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "Acticor Biotech SAS", "marketState": "REGULAR", "regularMarketPrice": 5.66, "messageBoardId": "finmb_283354646", "exchange": "FRA", "shortName": "ACTICOR BIOTECH  EO 1", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": 1.7985594, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.8399997, "fiftyTwoWeekLowChangePercent": 0.17427379, "fiftyTwoWeekRange": "4.82 - 10.55", "fiftyTwoWeekHighChange": -4.8900003, "fiftyTwoWeekHighChangePercent": -0.46350715, "fiftyTwoWeekLow": 4.82, "fiftyTwoWeekHigh": 10.55, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.6, "firstTradeDateMilliseconds": 1636095600000, "priceHint": 2, "regularMarketChange": 0.099999905, "regularMarketTime": 1683875702, "regularMarketDayHigh": 5.66, "regularMarketDayRange": "5.66 - 5.66", "regularMarketDayLow": 5.66, "regularMarketVolume": 499, "regularMarketPreviousClose": 5.56, "bid": 5.64, "ask": 6.54, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 5.66, "averageDailyVolume3Month": 8, "averageDailyVolume10Day": 0, "sharesOutstanding": 12305000, "bookValue": -0.213, "fiftyDayAverage": 6.3878, "fiftyDayAverageChange": -0.72780037, "fiftyDayAverageChangePercent": -0.11393599, "twoHundredDayAverage": 6.4621, "twoHundredDayAverageChange": -0.8021002, "twoHundredDayAverageChangePercent": -0.12412377, "marketCap": 77642176, "priceToBook": -26.57277, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "7V7.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "HOpital Bichat", "address2": "INSERM U1148 46 rue Henri Huchard", "city": "Paris", "zip": "75018", "country": "France", "phone": "33 6 76 23 38 13", "website": "https://www.acticor-biotech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Acticor Biotech SAS operates as a clinical stage biopharmaceutical company that develops drugs for the treatment for acute thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets platelet glycoprotein VI. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Gilles  Avenard M.D.", "age": 71, "title": "Founder, CEO & Director", "yearBorn": 1951, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Philippe  Billiald Ph.D., Pharm.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Martine  Jandrot-Perrus M.D., Ph.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric  Cohen", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sophie  Lebel-Binay Ph.D.", "age": 54, "title": "Deputy CEO, Chief Scientific Officer & GM", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aymeric  Humblot", "title": "Head of Fin. & Admin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yannick  Pletan M.D., M.Sc.", "age": 69, "title": "Deputy CEO, GM & Chief Medical Officer", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laurie  Jullien", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristell  Lebozec Ph.D.", "title": "Head of Pharmaceutical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Victoria  Rutman Pharm.D.", "title": "Head of Quality Assurance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}